Fruit and vegetable consumption to reduce brain damage
Eating plenty of spinach and blueberries may considerably limit brain damage from strokes and other neurological disorders, say US neuroscientists.
News, Analysis & Insights on Nutrition, Supplements, and Health
Eating plenty of spinach and blueberries may considerably limit brain damage from strokes and other neurological disorders, say US neuroscientists.
Eating soy protein on a regular basis may reduce a woman's chance of developing breast cancer by up to 22 percent, according to a new study.
Health ingredients manufacturer Fenchem says its newly certified range of non-GMO products will lead the way in building confidence in Chinese manufacturers, reports Dominique Patton.
Eating foods high in potassium is likely to have the same effect on blood pressure as taking potassium chloride supplements, suggests new research.
A team of US and Japanese researchers have declared that milk and meat from cloned cattle are likely to be safe for human consumption, although stressed that research in this area was still very much in its infancy, Tom Armitage reports.
A new study will test the impact of an Atkins-type high-meat, low-carbohydrate diet in late pregnancy on a mother's offspring.
Understanding the most extreme conditions for food products will bring gains for product formulation, particularly functional foods, on Earth, says Arla Food Ingredients, the firm that has developed a new yoghurt for consumption by NASA's astronauts,...
Researchers at Mexico's National Institute of Perinatology have found that women taking 100mg of vitamin C supplement a day from the 20th week of pregnancy may reduce the risk of their waters breaking too early.
Daily supplementation with fish or soy oil has been shown to increase elderly people's heart rate variability (HRV) and may stave off the risk of sudden cardiac death in the short term, write researchers in April's issue of Chest.
Health officials should place greater emphasis on healthy fats, including omega-3 fatty acids, to help reduce the high numbers of people with heart disease in the UK, said a new report released yesterday.
BioProgress has seen its share price slump nearly 40 per cent this morning on concerns that it would miss its financial targets, reports Phil Taylor.